Latest News about BIIB
Recent news which mentions BIIB
7 Growth Stocks to Buy to Tap Into a Hidden Bull Market
September 28, 2022
From InvestorPlace
Why Moderna Stock Lagged the Market Today
September 28, 2022
From Motley Fool
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
From Benzinga
Here's How Much $100 Invested In Biogen 20 Years Ago Would Be Worth Today
September 28, 2022
Tickers
BIIB
From Benzinga
Alphabet To $136? Plus This Analyst Slashes PT On United Natural Foods
September 28, 2022
From Benzinga
What The Biogen Chart Reveals As Stock Rallies Hard On Alzheimer's Data
September 28, 2022
Tickers
BIIB
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 28, 2022
From Benzinga
Biotech Stocks LLY, ESALY Gain on Biogen’s Positive Trial Results
September 28, 2022
From InvestorPlace
Why Is Prothena (PRTA) Stock Up 75% Today?
September 28, 2022
From InvestorPlace
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
September 28, 2022
From Benzinga
Why Is Acumen (ABOS) Stock Up 95% Today?
September 28, 2022
From InvestorPlace
This Analyst Believes Biogen's Lecanemab Data Not 'Slam Dunk' For Complete CMS Approval
September 28, 2022
From Benzinga
BMO Capital Upgrades Biogen: Here's What You Need To Know
September 28, 2022
Tickers
BIIB
From Benzinga
7 Biogen Analysts On Alzheimer's Drug Success As Stock Skyrockets 37%
September 28, 2022
Tickers
BIIB
From Benzinga
Why Biogen, Lilly, and Prothena Stocks Are Skyrocketing Today
September 28, 2022
From Motley Fool
Why Acumen Pharmaceuticals Stock Is Soaring Today
September 28, 2022
From Benzinga
Why Is Cassava Sciences (SAVA) Stock Heating Up Today?
September 28, 2022
From InvestorPlace
Why Is Biogen (BIIB) Stock Up 40% Today?
September 28, 2022
From InvestorPlace
Medicare coverage of Eisai and Biogen’s promising new Alzheimer’s therapy is ‘another bridge to cross’
September 28, 2022
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2022
September 28, 2022
From Benzinga
These Analysts Boost Price Targets On Biogen Following Positive Alzheimer's Drug Data, Shares Jump
September 28, 2022
Tickers
BIIB
From Benzinga
From Benzinga
A Biotech Breakthrough Means Big Gains for These 2 Stocks
September 28, 2022
From Motley Fool
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 28, 2022
From Benzinga
Is iPhone Demand Really Slowing Down?, Lyft Freezes Hiring, Biogen's New Drug Slows Alzheimer's Progression: Top Financial Media Stories Wednesday, Sept. 28
September 28, 2022
From Benzinga
What In The World Is Going On With Biogen (BIIB) Shares?
September 28, 2022
From Benzinga
From InvestorPlace
Why Cassava Sciences Shares Are Soaring Higher
September 28, 2022
From Benzinga
What's Going On With Eli Lilly Stock Shooting Higher Today
September 28, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
